Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1119]
News [2438]
Articles [146]
Editorials [8]
Conferences [102]
elearning [12]
Prostate cancer patients receiving androgen-deprivation therapies shown to be...
Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona...
Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19 ( Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerland )
7 May 2020
COVID-19: The situation in Peru and managing radiotherapy patients
Dr. Gustavo Sarria – Presidente en Sociedad de Radioterapia del Peru, Lima, Peru
COVID-19: The situation in Peru and managing radiotherapy patients ( Dr. Gustavo Sarria – Presidente en Sociedad de Radioterapia del Peru, Lima, Peru )
17 Apr 2020
Novel treatment strategies for prostate cancer: Senescence, senolytics and...
Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland
Novel treatment strategies for prostate cancer: Senescence, senolytics and myeloid derived suppressor cells ( Prof Andrea Alimonti - Institute of Oncology Research, Bellinzona, Switzerland )
9 Apr 2020
Shorter hormone therapy for prostate cancer
Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City...
Shorter hormone therapy for prostate cancer ( Dr André-Guy Martin - Centre Hospitalier Universitaire de Québec, Québec City, Canada )
24 Feb 2020
Micro-ultrasound for detection of clinically significant prostate cancer
Dr Davide Maffei - Humanitas University, Milan, Italy
Micro-ultrasound for detection of clinically significant prostate cancer ( Dr Davide Maffei - Humanitas University, Milan, Italy )
24 Feb 2020
Revolutionising imaging with PSMA PET in prostate cancer
Dr Bernard Henk-Erik Jansen - VU University Medical Center, Amsterdam, The...
Revolutionising imaging with PSMA PET in prostate cancer ( Dr Bernard Henk-Erik Jansen - VU University Medical Center, Amsterdam, The Netherlands )
24 Feb 2020
Follow up from MRI imaging for low-grade prostate cancer
Dr Henk B. Luiting - University of Groningen, Groningen, The Netherlands
Follow up from MRI imaging for low-grade prostate cancer ( Dr Henk B. Luiting - University of Groningen, Groningen, The Netherlands )
24 Feb 2020
Over-diagnosis of low-grade prostate cancer, good or bad?
Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium
Over-diagnosis of low-grade prostate cancer, good or bad? ( Prof Hendrik Van Poppel - KU Leuven, Leuven, Belgium )
24 Feb 2020
Updates in imaging for oligometastatic disease in urological cancers
Dr Tobias Maurer - University Hospital Hamburg-Eppendorf, Hamburg, Germany
Updates in imaging for oligometastatic disease in urological cancers ( Dr Tobias Maurer - University Hospital Hamburg-Eppendorf, Hamburg, Germany )
24 Feb 2020
PRIAS: Active surveillance for men with low risk prostate cancer
Prof Monique J. Roobol - Erasmus University Medical Center, Rotterdam, The...
PRIAS: Active surveillance for men with low risk prostate cancer ( Prof Monique J. Roobol - Erasmus University Medical Center, Rotterdam, The Netherlands )
24 Feb 2020
EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or...
Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma ( Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Feb 2020
KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC
Dr Julie Graff - Oregon Health & Science University, Portland, USA
KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC ( Dr Julie Graff - Oregon Health & Science University, Portland, USA )
19 Feb 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation